Community Mitigation Guidelines to Prevent Pandemic Influenza — United States, 2017
Open accessAbstract
When a novel influenza A virus with pandemic potential emerges, nonpharmaceutical interventions (NPIs) often are the most readily available interventions to help slow transmission of the virus in communities, which is especially important before a pandemic vaccine becomes widely available. NPIs, also known as community mitigation measures, are actions that persons and communities can take to help slow the spread of respiratory virus infections, including seasonal and pandemic influenza viruses.These guidelines replace the 2007 Interim Pre-pandemic Planning Guidance: Community Strategy for Pandemic Influenza Mitigation in the United States - Early, Targeted, Layered Use of Nonpharmaceutical Interventions (https://stacks.cdc.gov/view/cdc/11425). Several elements remain unchanged from the 2007 guidance, which described recommended NPIs and the supporting rationale and key concepts for the use of these interventions during influenza pandemics. NPIs can be phased in, or layered, on the basis of pandemic severity and local transmission patterns over time. Categories of NPIs include personal protective measures for everyday use (e.g., voluntary home isolation of ill persons, respiratory etiquette, and hand hygiene); personal protective measures reserved for influenza pandemics (e.g., voluntary home quarantine of exposed household members and use of face masks in community settings when ill); community measures aimed at increasing social distancing (e.g., school closures and dismissals, social distancing in workplaces, and postponing or cancelling mass gatherings); and environmental measures (e.g., routine cleaning of frequently touched surfaces).Several new elements have been incorporated into the 2017 guidelines. First, to support updated recommendations on the use of NPIs, the latest scientific evidence available since the influenza A (H1N1)pdm09 pandemic has been added. Second, a summary of lessons learned from the 2009 H1N1 pandemic response is presented to underscore the importance of broad and flexible prepandemic planning. Third, a new section on community engagement has been included to highlight that the timely and effective use of NPIs depends on community acceptance and active participation. Fourth, to provide new or updated pandemic assessment and planning tools, the novel influenza virus pandemic intervals tool, the Influenza Risk Assessment Tool, the Pandemic Severity Assessment Framework, and a set of prepandemic planning scenarios are described. Finally, to facilitate implementation of the updated guidelines and to assist states and localities with prepandemic planning and decision-making, this report links to six supplemental prepandemic NPI planning guides for different community settings that are available online (https://www.cdc.gov/nonpharmaceutical-interventions).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The variation in cumulative infection rates can be explained by a combination of factors including policies enacted by governments to encourage mask use and reduce social interaction, presence of escape variants, testing and contact tracing capacity, previous exposure to other coronaviruses, baseline patterns of social interaction, and more.
“This variation can be explained by a combination of factors including policies enacted by governments to encourage mask use and reduce social interaction,48, 49, 50 presence of escape variants, testing and contact tracing capacity,51, 52 previous exposure to other coronaviruses,53 baseline patterns of social interaction, and more.”
From Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis (2022) · cites this paper as [49]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Re-emergence of fatal human influenza A subtype H5N1 disease
Peiris, J., Yu, W., Leung, C., Cheung, C., Ng, W., Nicholls, J., Ng, T., Chan, K., Lai, S., Lim, W., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15595-5 · Cited by 812 · see citing works
Public health interventions and epidemic intensity during the 1918 influenza pandemic
Hatchett, R. J., Mecher, C. E., & Lipsitch, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610941104 · Cited by 778 · cited 1× · see citing works
“cities during the 1918 pandemic (47,48) or that simulated pandemic scenarios as they might occur in the future (49–51).”
BackgroundTalaat, M., Afifi, S., Dueger, E., El-Ashry, N., Marfin, A., Kandeel, A., Mohareb, E., & El-Sayed, N. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1704.101353 · Cited by 238 · see citing works
Exposure to Influenza Virus Aerosols During Routine Patient Care
Bischoff, W. E., Swett, K., Leng, I., & Peters, T. R. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis773 · Cited by 226 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Chu, D. K., Akl, E. A., Duda, S., Solo, K., Yaacoub, S., Schünemann, H. J., Chu, D. K., Akl, E. A., El-harakeh, A., Bognanni, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31142-9 · Cited by 3,843 · see citing works
Mobile phone data for informing public health actions across the COVID-19 pandemic life cycle
Oliver, N., Lepri, B., Sterly, H., Lambiotte, R., Deletaille, S., De Nadai, M., Letouzé, E., Salah, A. A., Benjamins, R., Cattuto, C., et al. (2020) · Science Advances · doi:10.1126/sciadv.abc0764 · Cited by 631 · see citing works
Fong, M. W., Gao, H., Wong, J. Y., Xiao, J., Shiu, E. Y. C., Ryu, S., & Cowling, B. J. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2605.190995 · Cited by 633 · see citing works
Moon, M. J. (2020) · Public Administration Review · doi:10.1111/puar.13214 · Cited by 423 · see citing works
Bundgaard, H., Bundgaard, J. S., Raaschou-Pedersen, D. E. T., von Buchwald, C., Todsen, T., Norsk, J. B., Pries-Heje, M. M., Vissing, C. R., Nielsen, P. B., Winsløw, U. C., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m20-6817 · Cited by 388 · see citing works
Barber, R. M., Sorensen, R. J. D., Pigott, D. M., Bisignano, C., Carter, A., Amlag, J. O., Collins, J. K., Abbafati, C., Adolph, C., Allorant, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00484-6 · Cited by 298 · see citing works
COVID-19: Implications for Physical Activity, Health Disparities, and Health Equity
Hasson, R., Sallis, J. F., Coleman, N., Kaushal, N., Nocera, V. G., & Keith, N. (2022) · American Journal of Lifestyle Medicine · doi:10.1177/15598276211029222 · Cited by 100 · see citing works
- Authors
- Qualls, N., Levitt, A., Kanade, N., Wright-Jegede, N., Dopson, S., Biggerstaff, M., Reed, C., Uzicanin, A., CDC Community Mitigation Guidelines Work Group, Levitt, A., Dopson, S., Frank, M., Holloway, R., Koonin, L., Rasmussen, S., Redd, S., de la Motte Hurst, C., Kanade, N., Qualls, N., Rainey, J., Uzicanin, A., Biggerstaff, M., Jernigan, D., & Reed, C.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Office of Infectious Diseases (US)
- United States Department of Health and Human Services (US)
- National Center for Immunization and Respiratory Diseases (US)
- Venue
- MMWR. Recommendations and Reports
- Published
- 2017-04-21
- Volume
- 66
- Issue
- 1
- Pages
- 1-34
- ISSN
- 1057-5987 (ISSN-L)
- 1545-8601
- PMC
- PMC5837128
- OpenAlex
- W2605415194
- Cited by
- 471
- References
- 4
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 25 · 2023: 47 · 2022: 76 · 2021: 120 · 2020: 169 · 2019: 13 · 2018: 3 · 2017: 3
- FWCI
- 40.28
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- public-domain
- Locations
- MMWR Recommendations and Reports (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention
- Office of Public Health Preparedness and Response
- National Center for Immunization and Respiratory Diseases
- National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Health Professions › Emergency Medical Services › Disaster Response and Management
- Social Sciences › Sociology and Political Science › COVID-19 Prevention and Impact
- Keywords
- pandemic influenza, non-pharmaceutical interventions, pandemic influenza preparedness, social distancing, school closures, face masks, community participation, pandemic risk assessment, influenza A(H1N1)pdm09
- MeSH terms
- Community Participation, Humans, Influenza, Human, United States, Influenza A Virus, H1N1 Subtype, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review